Skip to main content
Caplight Logo









NucleoBio Corp

NucleoBio Corp

Private
San Antonio, TexasHealthcare & Life Scienceshttps://www.nucleobio.com/

Last Round

Accelerator

Jun 1, 2017

Total Funding Raised

$25,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

NucleoBio Corp is a biotechnology company that develops RNA-based assays and molecular diagnostics for precision oncology derived from peer-reviewed research.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical Devices, Medical AI

Business Model

B2B

Customer Profile

Usage-Based SaaS, Data as a Service

AI Layer

Application

Keywords

liquid biopsyprostate cancer testmolecular diagnosticsRNA diagnosticsprecision oncologydiagnostic AIcancer risk stratificationnon-invasive diagnosticsRNA biomarkersearly cancer detectionqPCRresearch use onlyRUOCLIA-certified labs

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NucleoBio Corp Comparables

Compare NucleoBio Corp with similar companies based on industry and business-model similarity.

NucleoBio Corp comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MiRNA Scientific
87%
Minomic International
85%
LynxDx
85%

NucleoBio Corp Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 1, 2017

Key People

Founding team and executive leadership

Charles Oyesile

Chief Executive Officer

Executive Team

NucleoBio Corp Investors

Notable investors and investment history

NucleoBio Corp investors
InvestorRounds
National Science FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2026

    Monthly visitors increased 480% MoM, reaching 2K.

NucleoBio Corp Filings

Explore SEC and related filing metadata, where available.

NucleoBio Corp filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NucleoBio Corp's valuation, stock price, and market status.

Is NucleoBio Corp a public or private company?

NucleoBio Corp is a private company.

What is the current stock price of NucleoBio Corp?

NucleoBio Corp is a private company with no public stock price. No recent secondary market data is available.

How much is NucleoBio Corp worth (valuation)?

Valuation information for NucleoBio Corp is not publicly available.

Can I buy NucleoBio Corp stock?

NucleoBio Corp shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was NucleoBio Corp's last funding round?

Funding round information for NucleoBio Corp is not publicly available.

Who are the main investors in NucleoBio Corp?

Investor information for NucleoBio Corp is not publicly disclosed.

Will NucleoBio Corp IPO soon?

No public IPO plans have been announced for NucleoBio Corp.

How can I track NucleoBio Corp secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NucleoBio Corp's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Antonio, Texas
Employee Range4
Year Founded2017
Last FundingJun 1, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?